{"id":"https://openalex.org/W2255382886","doi":"https://doi.org/10.1177/1060028015597915","title":"New Insulin Glargine 300 U/mL for the Treatment of Type 1 and Type 2 Diabetes Mellitus","display_name":"New Insulin Glargine 300 U/mL for the Treatment of Type 1 and Type 2 Diabetes Mellitus","alternate_titles":[],"publication_year":2015,"publication_date":"2015-08-03","ids":{"openalex":"https://openalex.org/W2255382886","doi":"https://doi.org/10.1177/1060028015597915","mag":"2255382886","pmid":"https://pubmed.ncbi.nlm.nih.gov/26238470"},"language":"en","primary_location":{"id":"doi:10.1177/1060028015597915","doi":"https://doi.org/10.1177/1060028015597915","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1060028015597915","pdf_url":null,"source":{"id":"https://openalex.org/S113426163","display_name":"Annals of Pharmacotherapy","issn_l":"0012-6578","issn":["0012-6578","1060-0280","1542-6270"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Pharmacotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2255382886"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052956709","display_name":"Jennifer D. Goldman","orcid":"https://orcid.org/0000-0002-9617-3998","observed_orcids":["https://orcid.org/0000-0002-9617-3998"]},"institutions":[{"id":"https://openalex.org/I165817395","display_name":"Massachusetts College of Pharmacy and Health Sciences","ror":"https://ror.org/02fvywg07","country_code":"US","type":"education","lineage":["https://openalex.org/I165817395"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jennifer Goldman","raw_affiliation_strings":["MCPHS University, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MCPHS University, Boston, MA, USA","institution_ids":["https://openalex.org/I165817395"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5057977258","display_name":"John Raymond White","orcid":"https://orcid.org/0000-0003-2112-7185","observed_orcids":["https://orcid.org/0000-0003-2112-7185"]},"institutions":[{"id":"https://openalex.org/I170632171","display_name":"Washington State University Spokane","ror":"https://ror.org/04vfs5h36","country_code":"US","type":"education","lineage":["https://openalex.org/I170632171","https://openalex.org/I72951846"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John R White","raw_affiliation_strings":["Washington State University, Spokane, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington State University, Spokane, WA, USA","institution_ids":["https://openalex.org/I170632171"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":1.0846,"has_fulltext":false,"cited_by_count":41,"citation_normalized_percentile":{"value":0.7135255,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"49","issue":"10","first_page":"1153","last_page":"1161"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.9634000062942505,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.9634000062942505,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.033799998462200165,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11171","display_name":"Diabetes and associated disorders","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/insulin-glargine-300-u-ml","display_name":"insulin glargine 300 U/mL","score":0.9430000185966492},{"id":"https://openalex.org/keywords/long-acting-basal-insulin","display_name":"long-acting basal insulin","score":0.8600000143051147},{"id":"https://openalex.org/keywords/type-1-diabetes","display_name":"type 1 diabetes","score":0.9570000171661377},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":1.0},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8309999704360962},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8809999823570251},{"id":"https://openalex.org/keywords/nocturnal-hypoglycemia","display_name":"nocturnal hypoglycemia","score":0.9980000257492065},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.9190000295639038},{"id":"https://openalex.org/keywords/insulin-dose","display_name":"insulin dose","score":0.5979999899864197}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.880803108215332},{"id":"https://openalex.org/C2779920387","wikidata":"https://www.wikidata.org/wiki/Q417317","display_name":"Insulin glargine","level":4,"score":0.821799099445343},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.6590083837509155},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6384553909301758},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.6323683857917786},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.5790078043937683},{"id":"https://openalex.org/C2781232474","wikidata":"https://www.wikidata.org/wiki/Q124407","display_name":"Type 1 diabetes","level":3,"score":0.5229737758636475},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5181401968002319},{"id":"https://openalex.org/C2777538456","wikidata":"https://www.wikidata.org/wiki/Q311213","display_name":"Glycated hemoglobin","level":4,"score":0.5104478597640991},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.488779753446579},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4830246865749359},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.46454310417175293},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4589383006095886},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4478517472743988}],"mesh":[{"descriptor_ui":"D000069036","descriptor_name":"Insulin Glargine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000069036","descriptor_name":"Insulin Glargine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000069036","descriptor_name":"Insulin Glargine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1177/1060028015597915","doi":"https://doi.org/10.1177/1060028015597915","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1060028015597915","pdf_url":null,"source":{"id":"https://openalex.org/S113426163","display_name":"Annals of Pharmacotherapy","issn_l":"0012-6578","issn":["0012-6578","1060-0280","1542-6270"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Pharmacotherapy","raw_type":"journal-article"},{"id":"pmid:26238470","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26238470","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Annals of pharmacotherapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W1544349623","https://openalex.org/W1545770620","https://openalex.org/W1613501644","https://openalex.org/W1849264946","https://openalex.org/W1975663485","https://openalex.org/W1984640659","https://openalex.org/W1995411908","https://openalex.org/W2001756472","https://openalex.org/W2017534125","https://openalex.org/W2036478296","https://openalex.org/W2058777107","https://openalex.org/W2065510740","https://openalex.org/W2079335866","https://openalex.org/W2089128745","https://openalex.org/W2100633491","https://openalex.org/W2111876001","https://openalex.org/W2139040359","https://openalex.org/W2150617942","https://openalex.org/W2153917442","https://openalex.org/W2158144637","https://openalex.org/W2160943334","https://openalex.org/W2168959099","https://openalex.org/W2172193326","https://openalex.org/W2211234866","https://openalex.org/W4230570152"],"related_works":["https://openalex.org/W7098691607","https://openalex.org/W2726082861","https://openalex.org/W1981633674","https://openalex.org/W7100428010","https://openalex.org/W4230570152","https://openalex.org/W1846329661","https://openalex.org/W2316521341","https://openalex.org/W2100633491","https://openalex.org/W2315702610"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"describe":[2],"the":[3,6,22,47,76,103,167,213,247],"studies":[4,74,110],"evaluating":[5],"efficacy":[7,77,87],"and":[8,28,51,56,64,88,113,144],"safety":[9,79,89],"of":[10,24,39,80,90,135,215],"new":[11],"insulin":[12,20,52,97,206,239],"glargine":[13,53,98],"300":[14,54],"U/mL":[15,100],"(Gla-300)":[16],"as":[17,234],"a":[18,126,152,186,204,232],"basal":[19,238],"in":[21,62,102,111,131,151,185],"treatment":[23],"type":[25,29],"1":[26],"(T1DM)":[27],"2":[30],"(T2DM)":[31],"diabetes":[32],"mellitus.":[33],"DATA":[34,69,84],"SOURCES:":[35],"A":[36],"literature":[37],"search":[38],"MEDLINE":[40],"was":[41,149,156,177,209],"conducted":[42],"(January":[43],"2008-June":[44],"2015)":[45],"using":[46],"terms":[48],"U300,":[49],"Gla-300,":[50],"units/mL":[55],"supplemented":[57],"with":[58,96,138,158,165,173,198,201,212,222,242,246],"congress":[59],"abstracts":[60],"published":[61],"2014":[63],"2015.":[65],"STUDY":[66],"SELECTION":[67],"AND":[68],"EXTRACTION:":[70],"All":[71],"English":[72],"language":[73],"assessing":[75],"and/or":[78],"Gla-300":[81,92,118,145,155,174,199,208,229],"were":[82],"evaluated.":[83],"SYNTHESIS:":[85],"The":[86],"once-daily":[91],"has":[93],"been":[94],"compared":[95,164,200],"100":[99],"(Gla-100)":[101],"EDITION":[104],"trials,":[105],"6":[106],"phase-3,":[107],"multinational,":[108],"open-label":[109],"T1DM":[112,243],"T2DM.":[114],"Across":[115],"these":[116],"studies,":[117],"consistently":[119],"demonstrated":[120],"glycemic":[121],"control":[122],"comparable":[123,159,219],"to":[124,183,220],"Gla-100;":[125,166],"mean":[127],"(standard":[128],"error)":[129],"change":[130],"glycated":[132],"hemoglobin":[133],"A1c":[134],"-1.02%":[136],"(0.03)":[137],"both":[139],"Gla-100":[140,176],"(n":[141,146],"=":[142,147,181],"1235)":[143],"1239)":[148],"seen":[150],"patient-level":[153,187],"meta-analysis.":[154,188],"associated":[157],"or":[160,244],"reduced":[161],"nocturnal":[162,171],"hypoglycemia":[163,172],"relative":[168],"risk":[169],"for":[170,194,240,249],"versus":[175],"0.75":[178],"(95%":[179],"CI":[180],"0.68":[182],"0.83)":[184],"There":[189],"is":[190],"also":[191],"some":[192],"evidence":[193],"less":[195],"weight":[196],"gain":[197],"Gla-100,":[202],"despite":[203],"higher":[205],"dose.":[207],"well":[210],"tolerated,":[211],"number":[214],"adverse":[216],"events":[217],"being":[218],"that":[221,228],"Gla-100.":[223],"CONCLUSIONS:":[224],"These":[225],"results":[226],"suggest":[227],"may":[230],"have":[231],"place":[233],"an":[235],"alternative,":[236],"long-acting":[237],"patients":[241],"T2DM,":[245],"possibility":[248],"improved":[250],"tolerability.":[251]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2255382886","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":13},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
